Feb. 24, 2005 — The U.S. Food and Drug Administration (FDA) approved in November and December 2004 revisions to safety labeling to advise healthcare professionals of the following changes: use of ...

PLAINSBORO, N.J., July 16, 2015 /PRNewswire/ -- Novo Nordisk announced today the U.S. Food and Drug Administration (FDA) approval of FlexPro® PenMate®, designed for users of Norditropin® FlexPro® 5 mg ...

PRINCETON, N.J., Sept. 21 -- Novo Nordisk today announced that Norditropin(R) (somatropin [rDNA origin] injection) received approval from the U.S. Food and Drug Administration (FDA) for the treatment ...

Norditropin's injection pen slides inside the new FlexPro PenMate so that its needle is hidden during the injection.--Courtesy of Novo Nordisk Novo Nordisk ($NVO ...

To earn CME related to this news article, click here. January 7, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to warn of sudden death reports in pediatric ...

NORDITROPIN NORDIFLEX PEN (Somatropin) 30mg/3mL injection by Novo Nordisk The Norditropin (somatropin [rDNA origin] injection) NordiFlex 30mg/3mL prefilled pen has been made available by Novo Nordisk.

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Norditropin® FlexPro® is a dial-a-dose pen containing the active ...

PRINCETON, N.J. The Food and Drug Administration has approved a Novo Nordisk treatment for growth hormone disorders, the Danish drug maker announced Wednesday. The agency approved Norditropin FlexPro ...

Truth matters. Community matters. Your support makes both possible. LAist is one of the few places where news remains independent and free from political and corporate influence. Stand up for truth ...

COPENHAGEN, March 3 (Reuters) - The U.S. Food and Drug Administration has approved Danish drugmaker Novo Nordisk's growth hormone injection pen Norditropin Flexpro, the company said on Wednesday.

Novo Nordisk announced that the Food and Drug Administration (FDA) has approved a new 30mg/3.0mL strength of Norditropin (somatropin [rDNA origin] injection) FlexPro pen. Somatotropin binds to a ...

Co announces that Norditropin (somatropin [rDNA origin] injection) received FDA approval for the treatment of short stature in children with Noonan syndrome. Noonan syndrome is defined as an autosomal ...